Decreasing Depression & Anxiety Levels

A descriptive study that compares the depression and anxiety levels of patients before and after using Wellnite

19% of adults are estimated to have had an anxiety disorder in the past year.

Nearly 8% of adults in the US are suffering from depression.

Over half of individuals with depression report difficulty with completing daily activities.

A further 31% of adults are estimated to have had an anxiety disorder at some point in their lifetime. 

 

The GAD-7 (anxiety) and PHQ-9 (depression disorders) are some of the gold standard techniques that are used to measure and classify these conditions. 

The PHQ-9 is a nine-item screening questionnaire used to measure depression. The questionnaire has a maximum score of 27, with higher scores indicating the severity of depression.

The GAD-7 is a screening questionnaire for generalized anxiety disorder. The questionnaire has a maximum score of 21 with higher scores indicating the severity of anxiety. 

Anxiety & Depression Disorders:
Measurement Methods
There are different types of anxiety and depression disorders, including:generalized anxiety disorder, panic disorder, persistent depressive disorder, seasonal affective disorder, psychotic depression, postpartum depression, and various other phobia-related disorders.
 
Learn more about the types and symptoms here: Depression & Anxiety
 

Wellnite

Data-Driven Combination Therapy

We found that patients who used Wellnite's services lowered their GAD-7 and PHQ-9 scores overall. This descriptive analysis demonstrates that Wellnite is providing efficacious mental health services. This data will help us improve out pharmacological and non-pharmacological services to better tailor treatment to our users. 
 
Read the full descriptive analysis here.
 
Upon enrollment, patients had an average PHQ-9 score of 16, indicating moderately severe depression.
 
For the GAD-7, the average score was 14, indicating severe anxiety
 

BEFORE WELLNITE

Results:

Improved Outcomes

Chat Your Problems Away

Patients that used the chat based feature saw a 33% decrease in their depression score compared to those who did not. 

Getting It Just Right:

Not all medications work the same for everyone.

Patients who changed medications with Wellnite saw a ~30% decrease in PHQ-9 and GAD-7 scores compared to those who did not. 

Conclusion
Both average PHQ-9 and GAD-7 scores decreased during Wellnite use.

At enrollment, the cohort’s depression and anxiety were classified as moderately severe and moderate, respectively, according to initial average PHQ-9 and GAD-7 scores. At the end of the follow-up period, average depression and anxiety scores were classified as mild.

 

While the PHQ-9 and GAD-7 are not diagnostic tests, reduction in scores through the use of Wellnite shows promise in our service’s ability to ameliorate depressive and anxiety symptoms.

As Featured In

The nation's most affordable treatment for
depression and anxiety
We believe that people who struggle with these conditions already go through enough. No one needs the extra challenge of facing off with our complex healthcare system. 
Ready to feel better?
If you are in emotional distress, here are some resources for immediate help:
National Suicide Prevention Hotline:
Call 1-800-273-8255
Crisis Text Line:
Text Home to 741-741
If you’re having a medical or mental health emergency
Call  911 or go to your local ER
© Copyright Wellnite, Inc 2020
Have a question?
Email us anytime
Let's keep in touch
icons8-facebook_new.png
icons8-twitter.png
icons8-instagram_new.png